Trial Profile
To evaluate the tolerability, pharmacokinetics, pharmacodynamics of TQ-F3083 capsules in single-center, randomized, double-blind, placebo-controlled multi-dose, single, multiple administrations in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs TQ-F3083 (Primary)
- Indications Unspecified
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 30 Nov 2017 New trial record